Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.
about
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisA retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapyMeta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study.Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma.ASSURE vs. S-TRAC: conflicting results of adjuvant treatments for kidney cancer in the era of targeted agents and genomics.Outcomes of Patients With Late-Relapse Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Single Institution Experience.Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.
P2860
Q26786160-BEBD1044-FBB6-413B-80B9-06D1014AA39FQ36092829-14CB7323-2F21-42FB-AE63-80A07E339167Q37536769-FF7BC74B-4A79-41E9-B196-73779224C88BQ37657236-A1C0E023-06A1-4F43-9629-79E706049AF5Q38543085-DF5970EB-C085-4768-A487-F67F80C17C00Q38906250-C0AC3888-6949-4210-9FE6-030AE4BDE60CQ38907399-EAE1E75E-0E44-4B3F-BFBC-9B6B8F96E3C0Q42370353-34574489-D9DE-47E6-9F29-CC1B7580366AQ47149978-A1FD9487-BF5E-4588-8498-D424666606E8Q55101776-8FA5C951-2FED-458D-B776-71C244003A75
P2860
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic significance of hos ...... treated with targeted therapy.
@en
type
label
Prognostic significance of hos ...... treated with targeted therapy.
@en
prefLabel
Prognostic significance of hos ...... treated with targeted therapy.
@en
P2093
P2860
P50
P1433
P1476
Prognostic significance of hos ...... treated with targeted therapy.
@en
P2093
Cinzia Ortega
Cora N Sternberg
Francesco Massari
Giovanni Muzzonigro
Linda Cerbone
Lisa Derosa
Luciano Burattini
Michele Milella
Mimma Rizzo
Sergio Bracarda
P2860
P2888
P304
P356
10.1007/S11523-014-0356-3
P50
P577
2015-01-06T00:00:00Z